Teledyne Technologies
TDY
604.15
-18.07
-2.90%
Teledyne Technologies
US · TDY
#713 by market cap
Listed 1970
604.15
-18.07
-2.90%
Live - 5344 symbols - heartbeat 530s ago
· 2026-10-08 07:34
Pre-market
601.82
-0.39%
After-hours
604.15
0.00%
- Market cap
- 28.01B
- P/E (TTM)i
- 29.23
- P/Bi
- 2.56
- EPSi
- 18.88
- Div yieldi
- 0.00%
- 52W posi
- 56%
Reader sentiment
Are you bullish or bearish on TDY?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.92, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +7.86% YoY
Margins
- Gross margin
- 42.76%
- Operating margin
- 18.80%
- Net margin
- 14.63%
Key ratios & quality
- Enterprise valuei
- 30.16B
- PEG ratioi
- 6.80
- Altman Z-Scorei
- 4.92
PEG uses trailing P/E against the 3-year net income growth rate (4.30%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.16B | 3.09B | 4.61B | 5.46B | 5.64B | 5.67B | -- | 6.12B |
| Gross profit | 1.24B | 1.18B | 1.84B | 2.33B | 2.44B | 2.43B | -- | 2.61B |
| Selling & admin expenses | 715.10M | 662.00M | 1.07B | 804.00M | 852.00M | 902.60M | -- | 931.10M |
| Research & development | -- | -- | -- | 352.20M | 356.30M | 292.60M | -- | 317.30M |
| Operating profit | 491.70M | 480.10M | 624.30M | 972.40M | 1.03B | 1.04B | -- | 1.15B |
| Pretax profit | 473.70M | 469.70M | 533.80M | 908.10M | 958.90M | 937.90M | -- | 1.09B |
| Tax | 71.40M | 67.80M | 88.50M | 119.20M | 72.30M | 117.20M | -- | 198.80M |
| Net profit | 402.30M | 401.90M | 445.30M | 788.90M | 886.60M | 820.70M | -- | 895.70M |
| Basic EPS | 11 | 11 | 10 | 17 | 19 | 17 | -- | 19 |
| Diluted EPS | 10.73 | 10.62 | 10.05 | 16.53 | 18.49 | 17.21 | -- | 18.88 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.45B | 1.51B | 1.54B | 1.61B | 1.56B | 1.66B |
| Gross profit | 619.50M | 644.60M | 659.50M | 691.20M | 673.80M | 738.10M |
| Selling & admin expenses | 233.90M | 229.40M | 238.20M | 229.60M | 237.40M | 258.70M |
| Research & development | 74.30M | 82.40M | 83.40M | 77.20M | 84.60M | 90.20M |
| Operating profit | 259.30M | 278.20M | 282.80M | 329.50M | 294.20M | 333.20M |
| Pretax profit | 238.90M | 260.60M | 273.80M | 321.20M | 278.70M | 321.30M |
| Tax | 50.10M | 50.20M | 52.90M | 45.60M | 51.90M | 69.60M |
| Net profit | 188.80M | 210.40M | 220.90M | 275.60M | 226.80M | 251.70M |
| Basic EPS | 4 | 4 | 5 | 6 | 5 | 5 |
| Diluted EPS | 3.99 | 4.43 | 4.65 | 5.84 | 4.85 | 5.37 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.31B | 1.72B | 2.43B | 2.82B | 2.98B | -- | 2.94B | 3.06B |
| Cash & ST investments | 199.50M | 673.10M | 474.70M | 638.10M | 648.30M | -- | 649.80M | 352.40M |
| Inventory | 393.40M | 347.30M | 752.90M | 890.70M | 917.70M | -- | 914.40M | 1.04B |
| Total assets | 4.58B | 5.08B | 14.43B | 14.35B | 14.53B | -- | 14.20B | 15.29B |
| Total current liabilities | 763.20M | 760.90M | 1.50B | 1.52B | 1.77B | -- | 1.26B | 1.86B |
| Short-term debt | 100.60M | 97.60M | -- | 300.10M | 600.10M | -- | 30.50M | 482.10M |
| Long-term debt | 750.00M | 680.90M | 4.10B | 3.62B | 2.64B | -- | 2.65B | 2.03B |
| Total liabilities | 1,865,100,000.00 | 1,856,200,000.00 | 6,808,300,000.00 | 6,181,100,000.00 | 5,302,100,000.00 | -- | 4,645,100,000.00 | 4,771,400,000.00 |
| Total equity | 2.71B | 3.23B | 7.62B | 8.17B | 9.23B | -- | 9.56B | 10.51B |
| Retained earnings | 2.93B | 3.33B | 3.77B | 4.56B | 5.45B | -- | 6.27B | 7.14B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.98B | 2.92B | 3.22B | 3.06B | 3.32B | 3.20B |
| Cash & ST investments | 461.50M | 310.90M | 528.60M | 352.40M | 521.40M | 340.10M |
| Inventory | 1.01B | 1.05B | 1.06B | 1.04B | 1.12B | 1.17B |
| Total assets | 15.05B | 15.14B | 15.37B | 15.29B | 15.49B | 15.28B |
| Total current liabilities | 1.36B | 1.76B | 1.80B | 1.86B | 1.89B | 1.47B |
| Short-term debt | 200.00K | 450.20M | 450.20M | 482.10M | 450.10M | 100.00K |
| Long-term debt | 2.96B | 2.17B | 2.08B | 2.03B | 2.03B | 2.03B |
| Total liabilities | 5,117,100,000.00 | 4,751,900,000.00 | 4,807,900,000.00 | 4,771,400,000.00 | 4,788,600,000.00 | 4,361,900,000.00 |
| Total equity | 9.93B | 10.38B | 10.56B | 10.51B | 10.70B | 10.92B |
| Retained earnings | 6.46B | 6.67B | 6.87B | 7.14B | 7.37B | 7.62B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 482.10M | 618.90M | 824.60M | 486.80M | 836.10M | -- | 1.19B | 1.19B |
| Depreciation & amortization | 111.90M | 116.20M | 371.80M | 332.20M | 316.40M | -- | 309.90M | 336.30M |
| Free cash flow | 393.70M | 547.50M | 723.00M | 394.20M | 721.20M | -- | 1.11B | 1.07B |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | 0 | 0 | -- | -354.00M | -402.90M |
| Ending cash balance | 199.50M | 673.10M | 474.70M | 638.10M | 648.30M | -- | 649.80M | 352.40M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 242.60M | 226.60M | 343.10M | 379.00M | 234.00M | 315.20M |
| Depreciation & amortization | 80.70M | 86.50M | 84.50M | 84.60M | 87.20M | 85.70M |
| Free cash flow | 224.60M | 196.30M | 313.90M | 339.20M | 204.30M | 284.70M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | 0 | -400.00M | -- | -- |
| Ending cash balance | 461.50M | 310.90M | 528.60M | 352.40M | 521.40M | 340.10M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 16.27 | 13.52 | 8.21 | 9.99 | 10.19 | -- | 8.73 | 8.92 |
| ROA %i | 9.59 | 8.32 | 4.56 | 5.48 | 6.13 | -- | 5.70 | 6.07 |
| ROIC %i | 12.61 | 10.79 | 6.81 | 7.19 | 7.80 | -- | 7.05 | 7.44 |
| 5-year avg ROE %i | 14.51 | 14.39 | 13.39 | 12.80 | 11.64 | -- | 10.13 | 9.21 |
| EBIT margin %i | 15.64 | 15.72 | 13.83 | 18.27 | 18.39 | -- | 17.56 | 18.87 |
| FCF / sales %i | 12.44 | 17.74 | 15.67 | 7.22 | 12.80 | -- | 19.55 | 17.56 |
| Current ratioi | 1.72 | 2.26 | 1.62 | 1.85 | 1.69 | -- | 2.33 | 1.64 |
| Quick ratioi | 1.13 | 1.70 | 1.04 | 1.18 | 1.05 | -- | 1.48 | 0.92 |
| Debt / assetsi | 18.57 | 15.31 | 28.41 | 27.31 | 22.34 | -- | 19.64 | 17.29 |
| LT debt / equityi | 27.63 | 21.09 | 53.78 | 44.32 | 28.68 | -- | 28.88 | 20.54 |
| Interest coveragei | 23.56 | 31.70 | 6.12 | 11.17 | 13.40 | -- | 17.20 | 19.36 |
| Revenue CAGR (3Y) %i | 13.74 | 5.83 | 16.72 | 19.94 | 22.23 | -- | 7.11 | 3.86 |
| Net income CAGR (3Y) %i | 28.21 | 20.94 | 10.08 | 25.15 | 30.13 | -- | 22.53 | 4.30 |
| FCF CAGR (3Y) %i | 19.73 | 20.08 | 26.16 | 0.04 | 9.62 | -- | 15.30 | 39.67 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 8.61 | 8.72 | 8.11 | 8.92 | 9.05 | 9.16 |
| ROA %i | 5.59 | 5.85 | 5.47 | 6.07 | 6.11 | 6.41 |
| ROIC %i | 6.51 | 6.84 | 6.42 | 7.44 | 7.16 | 7.52 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 17.69 | 17.80 | 17.72 | 18.87 | 19.10 | 19.52 |
| FCF / sales %i | 18.33 | 16.13 | 17.29 | 17.56 | 16.93 | 17.92 |
| Current ratioi | 2.19 | 1.66 | 1.79 | 1.64 | 1.76 | 2.18 |
| Quick ratioi | 1.29 | 0.94 | 1.03 | 0.92 | 1.01 | 1.16 |
| Debt / assetsi | 19.70 | 17.29 | 16.48 | 17.29 | 15.98 | 13.27 |
| LT debt / equityi | 29.87 | 20.88 | 19.73 | 20.54 | 18.93 | 18.56 |
| Interest coveragei | -- | -- | -- | 19.36 | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Digital Imaging is the largest reported line at 52.25% of revenue, across 4 reported segments.
- Instrumentation follows at 23.33%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Digital Imaging52.25%
Instrumentation23.33%
Aerospace and Defense Electronics17.23%
Engineered Systems7.19%
Quote time 2026-10-08 07:34:48 · For reference only, not investment advice and not tailored to your situation.